Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Onyx Pharmaceuticals Inc. (ONXX)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: ONXX
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
Top Authors
Most frequent coverage on ONXX
SA Editor Miriam Metzinger
(528 followers)
Cramer's Mad Money - Oh, I'm a Lumberjack, Plum Creek's Okay (12/4/09)
(Sun, Dec 6)
Cramer's Mad Money - Hey Big Spenders (11/5/09)
(Fri, Nov 6)
Cramer's Stop Trading! The Total Data Hog (9/21/09)
(Tue, Sep 22)
More by SA Editor Miriam Metzinger on ONXX »
SA Editors
(179 followers)
Chart: Biotech Stocks - Revenue Per Employee
(Wed, May 31)
Chart: Biotech Stocks - Normalized Net Profit Margins
(Tue, May 23)
Chart: Biotech Stocks - SG&A Margin (MRQ)
(Thu, May 11)
More by SA Editors on ONXX »
TickerSense
(133 followers)
Russell 3000's Best and Worst Stocks, Week and Year to Date
(Sat, Apr 14)
Russell 3000's Best and Worst Stocks, Week and Year to Date
(Sun, Apr 8)
Russell 3000's Best and Worst Stocks, Week and Year to Date
(Sat, Mar 24)
More by TickerSense on ONXX »
Most followed authors on ONXX
TraderMark
(3719 followers)
41 Stocks Returning 10% or More Last Week
(Sun, Aug 17)
More by TraderMark on ONXX »
Bespoke Investment Group
(3496 followers)
Last Year's Best Stocks Have Been This Year's Worst
(Sun, Mar 2)
2007's Best, Worst Performers Faring Poorly in 2008
(Wed, Jan 16)
Best Performing Stocks YTD
(Thu, Dec 20)
More by Bespoke Investment Group on ONXX »
Don Dion
(2762 followers)
Biotech Fund IBB May Ride the M&A Frenzy, but It's Still Wildly Volatile
(Thu, Dec 13)
More by Don Dion on ONXX »
Newest authors on ONXX
Raymond Chung
(20 followers)
Onyx Pharmaceuticals: Is Nexavar the Next Avastin?
(Tue, Sep 22)
Onyx Pharmaceuticals: Good Reasons for Raising Capital, Investors Overly Concerned
(Thu, Aug 13)
More by Raymond Chung on ONXX »
Justin M. Hall
(672 followers)
Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers
(Sun, Sep 20)
Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up
(Fri, Sep 11)
More by Justin M. Hall on ONXX »
Prohost Biotech
(86 followers)
Onyx Pharmaceuticals: Could Acquiring Proteolix Be the Deal of the Year?
(Thu, Oct 22)
Onyx Pharmaceuticals: Nexavar Promising for Metastatic Breast Cancer
(Wed, Sep 23)
More by Prohost Biotech on ONXX »
Most commented on ONXX
Justin M. Hall
(672 followers)
Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers
(Sun, Sep 20)
Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up
(Fri, Sep 11)
More by Justin M. Hall on ONXX »
Michael Steinberg
(162 followers)
Pharmaceutical Dollar Rationing by Results
(Wed, Jul 1)
U.K. Limits 'Quality of Life' Meds to £30,000 a Year
(Sun, Oct 12)
More by Michael Steinberg on ONXX »
Zacks.com
(1051 followers)
Onyx to Acquire Cancer Drugmaker Proeolix
(Tue, Oct 13)
Bayer / Onyx Cancer Drug: Possible Additional Indication Looks Promising
(Sun, Sep 27)
Biotech Opportunities: Look for Decent Pipeline, Big Pharma Partnerships
(Tue, Jun 2)
More by Zacks.com on ONXX »